OPKO Health, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for OPKO Health, Inc..The latest application filed is for "hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one and pr".

Company Profile

4.37.37

OPKO Health, Inc. - Miami FL
Opko Health, Inc. - N/A
OPKO Health, Inc.; - US
EXEGENICS, INC., D/B/A OPKO HEALTH, INC. - Philadelphia PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Hydrochloride Salts Of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- A-spiro[4.5]decan-2-one And Pr App 20190375751 - Hu; Mengwei ; et al.	2019-12-12
Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazasp- iro[4,5]decan-2-one and preparation process therefor Grant 10,196,394 - Hu , et al. Fe	2019-02-05
Nk 1 Antagonists App 20180215729 - PALANI; Anandan ; et al.	2018-08-02
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 10,000,493 - Mergelsberg , et al. June 19, 2	2018-06-19
Heteroaryl Carbonitriles For The Treatment Of Disease App 20180153872 - HSIAO; Jane H. ; et al.	2018-06-07
NK.sub.1 antagonists Grant 9,969,711 - Palani , et al. May 15, 2	2018-05-15
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 9,822,116 - Wu , et al. November 21, 2	2017-11-21
Nk1 Antagonists App 20170283434 - Paliwal; Sunil ; et al.	2017-10-05
NK.sub.1 antagonists Grant 9,688,693 - Paliwal , et al. June 27, 2	2017-06-27
Nk 1 Antagonists App 20170029403 - Palani; Anandan ; et al.	2017-02-02
Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases Grant 9,551,721 - Moola , et al. January 24, 2	2017-01-24
Process And Intermediates For The Synthesis Of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20170008893 - Mergelsberg; Ingrid ; et al.	2017-01-12
NK.sub.1 antagonists Grant 9,469,629 - Palani , et al. October 18, 2	2016-10-18
Hypersulfated Disaccharide Formulations App 20160250242 - AHMED; Tahir	2016-09-01
Process And Intermediates For The Synthesis Of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20160145256 - Wu; George G. ; et al.	2016-05-26
Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxy-methyl]-8-phenyl-1,7-diaza-s- piro[4.5]decan-2-one and treatment methods using the same Grant 9,345,692 - Qiu , et al. May 24, 2	2016-05-24
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 9,260,428 - Mergelsberg , et al. February 16, 2	2016-02-16
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 9,249,144 - Wu , et al. February 2, 2	2016-02-02
Intravenous Formulations Of Neurokinin-1 Antagonists App 20160024092 - Wan; Jiansheng ; et al.	2016-01-28
Hypersulfated Disaccharides To Treat Elastase Related Disorders App 20150283157 - AHMED; Tahir ; et al.	2015-10-08
Tablet Formulations Containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Salts And Tablets Made Therefrom App 20150283121 - Qiu; Zhihui ; et al.	2015-10-08
Intravenous formulations of neurokinin-1 antagonists Grant 9,101,615 - Wan , et al. August 11, 2	2015-08-11
Hydrochloride Salts Of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazasp- Iro[4,5]decan-2-one And Preparation Process Therefor App 20150210693 - Hu; Mengwei ; et al.	2015-07-30
Hypersulfated disaccharide formulations Grant 9,006,211 - Ahmed April 14, 2	2015-04-14
Oral dosage form of 25-hydroxyvitamin D Grant 8,906,410 - Bishop , et al. December 9, 2	2014-12-09
Nk1 Antagonists App 20140336158 - Paliwal; Sunil ; et al.	2014-11-13
Nk1 Antagonists App 20140296196 - Palani; Anandan ; et al.	2014-10-02
NK1 antagonists Grant 8,796,299 - Paliwal , et al. August 5, 2	2014-08-05
NK1 antagonists Grant 8,754,216 - Shah , et al. June 17, 2	2014-06-17
Pharmaceutical Formulations: Salts Of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-sp- Iro[4.5]decan-2-one And Treatment Methods Using The Same App 20140088128 - Qiu; Zhihui ; et al.	2014-03-27
Process and Intermediates for the Synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20140031549 - Wu; George G. ; et al.	2014-01-30
Process And Intermediates For The Synthesis Of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Compounds App 20140024834 - MERGELSBERG; Ingrid ; et al.	2014-01-23
Hypersulfated Disaccharide Formulations App 20130345167 - AHMED; Tahir	2013-12-26
Hydrochloride Salts Of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazasp- Iro[4,5]decan-2-one And Preparation Process Therefor App 20130281477 - Hu; Mengwei ; et al.	2013-10-24
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one compounds Grant 8,552,191 - Mergelsberg , et al. October 8, 2	2013-10-08
Hypersulfated disaccharide formulations Grant 8,546,351 - Ahmed October 1, 2	2013-10-01
Hypersulfated Disaccharides To Treat Elastase Related Disorders App 20130203695 - Ahmed; Tahir ; et al.	2013-08-08
Hydrochloride salts of 8-[{1-(3,5-Bis-trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza- -spiro[4.5]decan-2-one and preparation process therefor Grant 8,470,842 - Hu , et al. June 25, 2	2013-06-25
Tablet Formulations Containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one Salts And Tablets Made Therefrom App 20130122088 - Qiu; Zhihui ; et al.	2013-05-16
Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-sp- iro[4.5]decan-2-one and treatment methods using the same Grant 8,404,702 - Qiu , et al. March 26, 2	2013-03-26
Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one salts and tablets made therefrom Grant 8,361,500 - Qiu , et al. January 29, 2	2013-01-29
Nk1 Antagonists App 20130023503 - Paliwal; Sunil ; et al.	2013-01-24
NK1 Antagonists App 20120295879 - Palani; Anandan ; et al.	2012-11-22
NK.sub.1 antagonists Grant 8,273,895 - Paliwal , et al. September 25, 2	2012-09-25
Hydrochloride salts of 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy)-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one and preparation process therefor Grant 8,178,550 - Hu , et al. May 15, 2	2012-05-15
Pharmaceutical Formulations:salts Of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-sp- Iro[4.5]decan-2-one And Treatment Methods Using The Same App 20120015921 - Qiu; Zhihui ; et al.	2012-01-19
Hypersulfated Glucopyranosides App 20110245197 - AHMED; Tahir	2011-10-06
NK.sub.1 antagonists Grant 8,026,364 - Shah , et al. September 27, 2	2011-09-27
Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaz- a-spiro[4.5]decan-2-one and treatment methods using the same Grant 7,981,905 - Qiu , et al. July 19, 2	2011-07-19
Hypersulfated Disaccharide Formulations App 20110136757 - AHMED; Tahir	2011-06-09
Nk1 Antagonists App 20110098468 - Paliwal; Sunil ; et al.	2011-04-28
NK.sub.1 antagonists Grant 7,902,366 - Paliwal , et al. March 8, 2	2011-03-08
Intravenous Formulations Of Neurokinin-1 Antagonists App 20110038925 - WAN; Jiansheng ; et al.	2011-02-17
Nk 1 Antagonists App 20100190759 - PALANI; Anandan ; et al.	2010-07-29
NK1 antagonists Grant 7,709,641 - Shah , et al. May 4, 2	2010-05-04
COMPOSITIONS AND METHODS FOR siRNA INHIBITION OF ANGIOGENESIS App 20080152654 - Reich; Samuel Jotham	2008-06-26

Company Registrations

NCAGE Code	5KMH6	OPKO HEALTH, INC.
CAGE Code	5KMH6	OPKO HEALTH, INC.
S.A.M. Registration	5KMH6 [783980345]	OPKO HEALTH, INC.
SEC	0000944809	Opko Health, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.